Immunocore Holdings plc (IMCR) — Business segments and KPIs
Revenue by business segment and geography for Immunocore Holdings plc, with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Sale of Therapies | 400.02M | 100.0% |
| Revenue by region | ||
| UNITED STATES | 257M | 64.2% |
| Europe | 131.42M | 32.9% |
| Rest of World | 11.60M | 2.9% |